RAPT Therapeutics, Inc.

Historical 13F Holders

Symbol
RAPT
CUSIP
75382E109
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 95 131 M $160 M
2024 Q4 97 127 M $199 M
2024 Q3 99 29.8 M $59.9 M
2024 Q2 122 33.0 M $101 M
2024 Q1 149 35.8 M $322 M
2023 Q4 122 37.2 M $925 M
2023 Q3 103 35.4 M $589 M
2023 Q2 102 34.1 M $637 M
2023 Q1 113 33.3 M $611 M
2022 Q4 100 34.0 M $673 M
2022 Q3 103 30.0 M $721 M
2022 Q2 90 29.7 M $543 M
2022 Q1 89 28.1 M $618 M
2021 Q4 112 30.8 M $1.13 B
2021 Q3 120 26.4 M $818 M
2021 Q2 134 29.1 M $925 M
2021 Q1 91 23.6 M $523 M
2020 Q4 93 20.4 M $404 M
2020 Q3 71 16.8 M $542 M
2020 Q2 56 15.1 M $444 M
2020 Q1 40 11.8 M $250 M
2019 Q4 29 9.17 M $252 M